ArchiMed-backed NAMSA acquires American Preclinical Services

NAMSA, which is backed by ArchiMed, has acquired American Preclinical Services, a provider of medical device and pharmaceutical testing.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this